AMAG Pharmaceuticals Inc

Type: Company
Name: AMAG Pharmaceuticals Inc
First reported Sep 11 2014 - Updated Sep 11 2014 - 2 reports

AMAG Pharmaceuticals Shares Up 15.8% Since SmarTrend's Buy Recommendation (AMAG)

Written on Thu, 09/11/2014 - 11:24amBy David DiazSmarTrend identified an Uptrend for AMAG Pharmaceuticals ( NASDAQ:AMAG ) on August 11th, 2014 at $20.91. In approximately 1 month, AMAG Pharmaceuticals has returned 15.76% as of today's recent price of ... [Published Comtex SmarTrend - Sep 11 2014]
First reported Sep 11 2014 - Updated Sep 11 2014 - 1 reports

AMAG Pharmaceuticals appoints new director

AMAG Pharmaceuticals, Inc., a specialty pharmaceutical company, has appointed John Fallon, senior vice president and chief physician executive at Blue Cross & Blue Shield of Massachusetts, or BCBSMA, to the company's board of directors. "John's deep experience ... [Published Individual.com - Sep 11 2014]
First reported Sep 08 2014 - Updated Sep 09 2014 - 3 reports

AMAG Pharmaceuticals appoints Dr John A. Fallon to board

Pharmaceutical company AMAG Pharmaceuticals (NasdaqGS:AMAG) disclosed on Monday the addition of Dr John Fallon, MD to its board of directors with effect from 5 September 2014. Currently, Dr Fallon serves as senior vice president and chief physician executive ... [Published Individual.com - Sep 09 2014]
First reported Sep 02 2014 - Updated Sep 02 2014 - 1 reports

Business Digest for Sept. 2, 2014

Follow Daily News Business Editor Bob Tremblay on Twitter @Bob Tremblay_MW. MutualOne supports Christa McAuliffe Library The MutualOne Charitable Foundation has made the second of three payments toward its $50,000 pledge to the Framingham Public Library ... [Published MetroWest Daily News - Sep 02 2014]
First reported Aug 29 2014 - Updated Aug 29 2014 - 1 reports

AMAG Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences

WALTHAM, Mass., Aug. 29, 2014 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. ( Nasdaq:AMAG ) today announced that company management will discuss AMAG's business and financial outlook, strategy and growth prospects at investor conferences taking place ... [Published Street Sweeper - Aug 29 2014]
First reported Aug 28 2014 - Updated Aug 28 2014 - 1 reports

AMAG Pharmaceuticals (AMAG) Showing Bullish Technicals

For a hedged play on AMAG Pharmaceuticals (AMAG), MarketIntelligenceCenter.com’s option-trade picking algorithms recommend the Feb. '15 $20.00 covered call for a net debit in the $18.98 area. That is also the break-even stock price for the covered call. ... [Published MarketIntelligenceCenter.com - Aug 28 2014]
First reported Aug 25 2014 - Updated Aug 25 2014 - 1 reports

AMAG appoints vice president of legal affairs and chief compliance officer

AMAG Pharmaceuticals, Inc., a specialty pharmaceutical company, has appointed Robert Blood as vice president of legal affairs and chief compliance officer. In this role, Mr Blood will be responsible for providing internal legal advice in connection with ... [Published Individual.com - Aug 25 2014]
First reported Aug 20 2014 - Updated Aug 20 2014 - 1 reports

AMAG Pharmaceuticals (AMAG) Showing Support Near $19.91

AMAG Pharmaceuticals (AMAG) presents a trading opportunity that offers a 11.05% return in just 184 days.A covered call on AMAG Pharmaceuticals at the $20.00 level expiring on Feb. '15 offers an assigned return rate of 11.05% or 21.92% annualized. This ... [Published MarketIntelligenceCenter.com - Aug 20 2014]
First reported Aug 19 2014 - Updated Aug 19 2014 - 1 reports

AMAG Pharmaceuticals (AMAG) Showing Support Near $19.92

After closing Monday at $20.31, AMAG Pharmaceuticals (AMAG) presents an attractive opportunity to get a 5.49% return in just 95 days, which is an annualized return of 21.07% (for comparison purposes only). To enter this trade, sell one Nov. '14 $20.00 ... [Published MarketIntelligenceCenter.com - Aug 19 2014]
First reported Aug 11 2014 - Updated Aug 12 2014 - 1 reports

AMAG Crosses Above Key Moving Average Level

In trading on Monday, shares of AMAG Pharmaceuticals, Inc. (AMAG) crossed above their 200 day moving average of $20.90, changing hands as high as $20.95 per share.. ... [Published Crawford Financial Planning - Aug 11 2014]
First reported Aug 11 2014 - Updated Aug 12 2014 - 3 reports

AMAG Pharmaceuticals Appoints Robert Blood as Vice President of Legal Affairs and Chief Compliance Officer

WALTHAM, Mass., Aug. 12, 2014 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced the appointment of Robert Blood, Esq. as vice president of legal affairs and chief compliance officer. Mr. Blood comes to AMAG with extensive experience ... [Published Scottrade - Aug 12 2014]
First reported Jul 07 2014 - Updated Jul 07 2014 - 1 reports

AMAG Pharmaceuticals (AMAG) Showing Support Near $20.24

A covered call identified by MarketIntelligececenter.com's patented algorithm on AMAG Pharmaceuticals (AMAG) could yield about 7.47% (19.76% annualized, for comparison purposes only) in 138 days. Pair a long position in the stock with the Nov. '14 $20.00 ... [Published MarketIntelligenceCenter.com - Jul 07 2014]

Quotes

"I am very excited about joining the AMAG board at this time," said Dr Fallon. "AMAG has an impressive record of achievement over the past couple of years, and I look forward to working with the board and management to help the company build on those successes."
...com's Artificial Intelligence Center have selected a covered call trade on AMAG Pharmaceuticals (http://www.marketintelligencecenter.com/symbol/AMAG "AMAG) that includes 18.84% downside protection. Sell one contract of the Feb. '15 $20.00 call for every 100 shares of AMAG for a net debit per share of about $18.96. If AMAG Pharmaceuticals closes at or above $20.00 at expiration, this trade will return 5.49% or 12.21% annualized. Support has been above $22.67 while resistance has been below $24.03. AMAG closed at $23.36 after trading between $23.01 and $23.69 Monday."
...senior vice president of legal affairs, general counsel and secretary at AMAG. "Robert's deep experience in the pharmaceutical and biotechnology industry and his knowledge and experience with the federal and state laws that govern the marketing and promotion of our products will be extremely valuable as we work to grow our existing product portfolio and build a diversified, multi-product pharmaceutical company that puts patients first."
...The publication, entitled "Multi-Institutional, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy of a Mucoadhesive Hydrogel (MuGard) in Mitigating Oral Mucositis Symptoms in Patients Being Treated With Chemoradiation Therapy for Cancers of the Head and Neck" discusses data on Access' post-marketing clinical trial that evaluated the efficacy of MuGard in controlling symptoms caused by oral mucositis in 120...

More Content

All (70) | News (29) | Reports (0) | Blogs (27) | Audio/Video (0) | Fact Sheets (0) | Press Releases (14)
sort by: Date | Relevance
AMAG Pharmaceuticals Shares Up 15.8% Since Smar... [Published Comtex SmarTrend - Sep 11 2014]
AMAG Pharmaceuticals Shares Up 15.8% Since Smar... [Published Individual.com - Sep 11 2014]
AMAG Pharmaceuticals appoints new director [Published Individual.com - Sep 11 2014]
Potential AMAG Pharmaceuticals (AMAG) Trade Has... [Published MarketIntelligenceCenter.com - Sep 11 2014]
AMAG Pharmaceuticals (AMAG) Trading Near $24.03... [Published MarketIntelligenceCenter.com - Sep 10 2014]
Potential AMAG Pharmaceuticals (AMAG) Trade Has... [Published Individual.com - Sep 09 2014]
Potential AMAG Pharmaceuticals (AMAG) Trade Has... [Published MarketIntelligenceCenter.com - Sep 09 2014]
AMAG Pharmaceuticals appoints Dr John A. Fallon... [Published Individual.com - Sep 09 2014]
AMAG Pharmaceuticals Announces Appointment of J... [Published Virtual Strategy Magazine - Sep 08 2014]
AMAG Pharmaceuticals Announces Appointment of J... [Published GlobeNewswire: Advertising News - Sep 08 2014]
AMAG Pharmaceuticals Announces Appointment of J... [Published Fat Pitch Financials - Sep 08 2014]
Business Digest for Sept. 3, 2014 [Published MetroWest Daily News - Sep 03 2014]
AMAG Pharmaceuticals (AMAG) Showing Bullish Tec... [Published MarketIntelligenceCenter.com - Sep 03 2014]
Business Digest for Sept. 2, 2014 [Published MetroWest Daily News - Sep 02 2014]
AMAG Pharmaceuticals (AMAG) Showing Bullish Tec... [Published MarketIntelligenceCenter.com - Sep 02 2014]
AMAG Pharmaceuticals, Inc. to Present at Upcomi... [Published GlobeNewswire: Acquisitions News - Aug 29 2014]
AMAG Pharmaceuticals, Inc. to Present at Upcomi... [Published Street Sweeper - Aug 29 2014]
AMAG Pharmaceuticals (AMAG) Showing Bullish Tec... [Published MarketIntelligenceCenter.com - Aug 28 2014]
Potential AMAG Pharmaceuticals (AMAG) Trade Has... [Published MarketIntelligenceCenter.com - Aug 27 2014]
AMAG appoints vice president of legal affairs a... [Published Individual.com - Aug 25 2014]
AMAG Pharmaceuticals (AMAG) Showing Support Nea... [Published MarketIntelligenceCenter.com - Aug 20 2014]
Business Digest for Aug. 19, 2014 [Published MetroWest Daily News - Aug 19 2014]
AMAG Pharmaceuticals (AMAG) Showing Support Nea... [Published MarketIntelligenceCenter.com - Aug 19 2014]
AMAG Pharmaceuticals (AMAG) Showing Bullish Tec... [Published MarketIntelligenceCenter.com - Aug 15 2014]
Access Pharmaceuticals Awarded Japan Patent For... [Published TickerTech.com - Aug 14 2014]
Potential AMAG Pharmaceuticals (AMAG) Trade Has... [Published MarketIntelligenceCenter.com - Aug 13 2014]
AMAG Pharmaceuticals Appoints Robert Blood as V... [Published GlobeNewswire: Advertising News - Aug 12 2014]
AMAG Pharmaceuticals Appoints Robert Blood as V... [Published Scottrade - Aug 12 2014]
Potential AMAG Pharmaceuticals (AMAG) Trade Has... [Published MarketIntelligenceCenter.com - Aug 12 2014]
AMAG Pharmaceuticals Inc. (AMAG): Deerfield Man... [Published InsiderMonkey.com - Aug 11 2014]
1 2 3
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Potential AMAG Pharmaceuticals (AMAG) Trade Has... [Published MarketIntelligenceCenter.com - Sep 11 2014]
After Wednesday’s trading in AMAG Pharmaceuticals (AMAG) the algorithms behind MarketIntelligenceCenter.com's Artifical Intelligence Center picked out a trade that offers a 4.77% or 10.74% (for comparison purposes only), while providing 21.08% downside ...
AMAG Pharmaceuticals (AMAG) Trading Near $24.03... [Published MarketIntelligenceCenter.com - Sep 10 2014]
A covered call identified by MarketIntelligececenter.com's patented algorithm on AMAG Pharmaceuticals (AMAG) could yield about 4.45% (22.25% annualized, for comparison purposes only) in 73 days. Pair a long position in the stock with the Nov. '14 $23.00 ...
Potential AMAG Pharmaceuticals (AMAG) Trade Has... [Published MarketIntelligenceCenter.com - Sep 09 2014]
The patented option trade-picking algorithms behind MarketIntelligenceCenter.com's Artificial Intelligence Center have selected a covered call trade on AMAG Pharmaceuticals (AMAG) that includes 18.84% downside protection. Sell one contract of the Feb. ...
AMAG Pharmaceuticals (AMAG) Showing Bullish Tec... [Published MarketIntelligenceCenter.com - Sep 03 2014]
MarketIntelligenceCenter.com's patented trade-picking algorithms have identified an attractive covered-call trade on AMAG Pharmaceuticals (AMAG). Look at the Feb. '15 $20.00 covered call for a net debit in the $18.66 area. This trade has a duration of ...
AMAG Pharmaceuticals (AMAG) Showing Bullish Tec... [Published MarketIntelligenceCenter.com - Sep 02 2014]
After closing Friday at $22.63, AMAG Pharmaceuticals (AMAG) presents an attractive opportunity to get a 5.10% return in just 171 days, which is an annualized return of 10.88% (for comparison purposes only). To enter this trade, sell one Feb. '15 $20.00 ...
1 2 3 4 5 6

Press Releases

sort by: Date | Relevance
AMAG Pharmaceuticals Announces Appointment of J... [Published GlobeNewswire: Advertising News - Sep 08 2014]
AMAG Pharmaceuticals, Inc. to Present at Upcomi... [Published GlobeNewswire: Acquisitions News - Aug 29 2014]
AMAG Pharmaceuticals Appoints Robert Blood as V... [Published GlobeNewswire: Advertising News - Aug 12 2014]
AMAG Pharmaceuticals, Inc. to Participate in Je... [Published GlobeNewswire: Advertising News - Aug 01 2014]
AMAG Pharmaceuticals Announces Second Quarter a... [Published GlobeNewswire: Acquisitions News - Jul 29 2014]
1 2 3
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.